- The endothelin ETA receptor antagonist BQ-123 normalizes the response of SHR aorta to Ca2+ channel activator.
The endothelin ET<SUB>A</SUB> receptor antagonist BQ-123 normalizes the response of SHR aorta to Ca<SUP>2+</SUP> channel activator.
European Journal of Pharmacology (1994)
Morel, et al.